ADHD Vyvanse and Menopause Issues
A study published in the June 2015 Journal of Psychopharmacology reports widespread cognitive decline of menopausal women. The areas of cognitive decline affect executive functions, most notably difficulties with time management, organization, memory, attention and problem solving. With approximately 90 million post-menopausal women in the U.S. with an average age of 52 at onset, these women live in a post-menopausal state for almost 1/3 of their lives.
Prior to this study, I hadn’t seen objective studies of ADHD like syndrome emerging during menopause, but I had seen numerous women presenting with suspected ADHD during menopause. My history taking with these women almost always reveals a history of pre-existing ADHD or sub-threshould multiple ADHD like symptoms. Regardless of the origin of the ADHD like symptoms, Vyvanse and other psychostimulants typically are quite helpful.
ADHD Vyvanse Dual Use
The medication Vyvanse primarily used in the treatment of adult ADHD, has also successfully treated cognitive issues of menopausal women promoting healthy cognitive aging as a major public health goal. ADHD Vyvanse research data shows a 41% overall improvement in executive function deficits compared to those receiving a placebo medication.
Benefits of Vyvanse Treatment
Vyvanse, also known as lisdexamfetamine or LDX, not only improves executive function in menopausal women, the medication has also been proven to show significant improvements in rating four out of the five subscales used in mental health evaluation and diagnosis which include:
- Organization and motivation for work
- Attention and concentration
- Alertness, effort, and processing speed
- Working memory and accessing recall
Comprehensive Evaluation Critical for Correct Diagnosis
Study results show that ADHD Vyvanse, LXD or lisdexamfetamine, show significant positive results. It is crucial however to confirm that the complaints of cognitive changes including loss of memory, or issues with executive function abilities are tied to the transition to menopause and do not point to another pathological cognitive impairment. Working with a psychiatrist experienced in this field is mandatory for a correct diagnosis or diagnoses to build the proper medication and treatment plan upon.
Call Dr. Hege for a confidential and comprehensive evaluation to determine the best course of treatment to meet your needs.